Purple Biotech LTD. balance sheet

At the end of fiscal 2020, Purple Biotech LTD. had total assets of $83.8m and shareholders' equity of $79.4m. It held $11.2m in cash against $0 of debt: net cash of $11.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Purple Biotech LTD.: balance sheet, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020
Cash and equivalents	4	5	4	11
Total current assets	8	9	8	59
Total assets	14	15	15	84
Total current liabilities	4	3	4	3
Total debt	0	0	0	0
Shareholders' equity	7	11	10	79
Net debt (negative = net cash)	−4	−5	−4	−11

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Purple Biotech LTD.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Purple Biotech LTD.